Crosshair Therapeutics is harnessing machine learning and a novel high-precision protein targeting technology to computationally design a new class of DNA-based therapeutics. Our unique targeting platform enables unrestricted access to the most difficult disease targets. We now have the capability to exploit intractable targets in oncology, aging and other indications of high unmet need.
